Company Name: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company. The company is engaged in the development of prescription drugs designed to treat rare neuromuscular and neurological diseases. The company’s lead product candidate is designed to treat Lambert-Eaton Myasthenic Syndrome (LEMS).

Ticker Symbol: CPRX (NASDAQ)

Company Website: www.catalystpharma.com

Social Media:

Catalyst Pharmaceutical Partners LinkedIn

Catalyst Pharmaceutical Partners Twitter

Headquarters: Coral Gables, FL